focus -WSS

focus

author：entertainment 2025-09-06 01:59:33 - browse：98875

Adobe

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday.

The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees. And it opens the door for other Medicare Advantage plans to potentially recoup huge sums of taxpayer-funded bonuses — even though many independent experts believe the quality rating system is flawed and doesn’t appropriately gauge quality of care for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services, the federal agency that oversees all Medicare programs, said it does not comment on litigation. In an interview, SCAN CEO Sachin Jain told STAT that if the company had not gotten its expected bonus money, it would have had to shave benefits and reduce what it pays hospitals and doctors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： 1 dead, 9 hurt in July 4th fireworks explosion

entertainment

WSS

1 dead, 9 hurt in July 4th fireworks explosion

First medicine developed to treat MASH expected to be approved soon

Former medical device CEO who sold dummy, plastic parts convicted of fraud

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

4 dead, 2 in stable condition in Philadelphia shooting: Police

Change Healthcare cyberattack prompts Medicare loan program

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Wikipedia

Tori Bowie and the unacceptable rates of Black maternal death

First medicine developed to treat MASH expected to be approved soon

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

How to save PrEP access — and even expand it

Amylyx ALS drug fails large clinical trial

Psychedelics group wrestles with new pharma identity

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

New air purifier tech could be key to improving indoor air quality

What it’s like to watch children die of measles

hotspot

A timeline of the missing Titanic tourist submersible

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

Elon Musk announces 'temporary limits' for reading Twitter posts

First medicine developed to treat MASH expected to be approved soon

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

explore

entertainment

focus

focus